Clinical Trial Update: Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial [Phase 2]

View source ↗

Summary

Phase 2 mechanistic clinical trial evaluating a probiotic mixture for metabolic dysfunction-associated steatotic liver disease (MASLD) and nonalcoholic fatty li…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatotic Liver Disease
• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• Probiotic mixture (Probiotic mixture)

Snippet

Sponsor: AB Biotics, SA | Conditions: MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease, Fatty Liver Disease, Nonalcoholic | Phase 2 | Status: NOT_YET_RECRUITING